Last reviewed · How we verify

NCT04006444: ALGOGER

Characterization of the Iatrogenic Drug Risk in Elderly Patients With Chronic Pain Who Consult the Pain Assessment and Treatment Centre at the Nimes University Hospital

Completed Last updated 8 September 2023
What this trial tests

trial in Iatrogenic Drug Risk in 100 participants. Completed in 16 June 2018.

Timeline
1 March 2018
Primary endpoint
16 June 2018
16 June 2018

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Nīmes
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date1 March 2018
Primary completion16 June 2018
Estimated completion16 June 2018
Sites1 location across France

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Nīmes

Who can join

Adults 65 to 100, any sex, with Iatrogenic Drug Risk or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic pain may be an additional risk factor for drug iatrogeny due to its management and also drug non-compliance in the geriatric population. it seems interesting to carry out an inventory of the iatrogenic risk before and after the consultation at the pain centre to enable us to identify the patients most at risk. This study would make it possible to characterize elderly patients with chronic pain, in order to consider, in a future study, setting up a pharmaceutical consultation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. What Is the Medication Iatrogenic Risk in Elderly Outpatients for Chronic Pain?
    Jambon J, Choukroun C, Roux-Marson C, Viel É, et al · · 2022 · PMID 35579486 · DOI 10.1097/wnf.0000000000000505

Verify or expand the search:

Other Centre Hospitalier Universitaire de Nīmes trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04006444.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing